News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Heerma Peter
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 3,091 shares
@ $8.2511, valued at
$25.5k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2023 |
4
| Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 1,550 shares
@ $21.9044, valued at
$34k
|
|
| 10/06/2022 |
4
| Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 3,042 shares
@ $25.68, valued at
$78.1k
|
|
| 02/02/2022 |
4
| Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Granted 9,840 shares
@ $0
Sold 1,125 shares
@ $27.4, valued at
$30.8k
Granted 39,360 options to buy
@ $27.5, valued at
$1.1M
Granted 9,840 options to buy
@ $0
Granted 8,000 options to buy
@ $0 |
|
| 01/26/2022 |
4
| Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 1,875 shares
@ $24.98, valued at
$46.8k
|
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 1,125 shares
@ $31.41, valued at
$35.3k
Sold 1,125 shares
@ $31.58, valued at
$35.5k
|
|
| 02/05/2021 |
4
| Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Granted 4,500 shares
@ $0 |
|
| 02/03/2021 |
4
| Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 563 shares
@ $30.75, valued at
$17.3k
Sold 563 shares
@ $28.91, valued at
$16.3k
|
|
| 01/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2020 |
4
| Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Sold 2,188 shares
@ $18.9, valued at
$41.4k
Sold 2,188 shares
@ $19.35, valued at
$42.3k
|
|
| 01/31/2020 |
4
| Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 9,000 shares
@ $0
Granted 55,000 options to buy
@ $15.46, valued at
$850.3k
Granted 9,000 options to buy
@ $0 |
|
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|